Severe Sepsis and Therapy with Activated Protein C
- 29 September 2005
- journal article
- editorial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 353 (13) , 1398-1400
- https://doi.org/10.1056/nejme058160
Abstract
Sepsis, severe sepsis, and septic shock represent a spectrum of increasingly severe diseases that result from serious infection and the body's response to microbiologic invasion. Population data suggest that 750,000 cases of severe sepsis occur in the United States annually; this illness is responsible for as many deaths as acute myocardial infarction (215,000, or 9.3 percent of deaths from all causes).13 Almost every discipline in medicine must deal with this disease, from neonatology to orthopedic surgery to emergency medicine, though much of the management is performed by critical care physicians in intensive care units.The pathogenic mechanisms underlying severe . . .Keywords
This publication has 10 references indexed in Scilit:
- Drotrecogin Alfa (Activated) for Adults with Severe Sepsis and a Low Risk of DeathNew England Journal of Medicine, 2005
- Use of intensive care at the end of life in the United States: An epidemiologic study*Critical Care Medicine, 2004
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCritical Care Medicine, 2004
- Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsisCritical Care Medicine, 2003
- Assessing the Use of Activated Protein C in the Treatment of Severe SepsisNew England Journal of Medicine, 2002
- Risks and Benefits of Activated Protein C Treatment for Severe SepsisNew England Journal of Medicine, 2002
- An Economic Evaluation of Activated Protein C Treatment for Severe SepsisNew England Journal of Medicine, 2002
- Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of careCritical Care Medicine, 2001
- Efficacy and Safety of Recombinant Human Activated Protein C for Severe SepsisNew England Journal of Medicine, 2001
- Pathogenetic Mechanisms of Septic ShockNew England Journal of Medicine, 1993